- CryoPort Inc CYRX shares tumbled 40 percent to $2.11. Cryoport reported a proposed public offering of common stock.
- HTG Molecular Diagnostics Inc HTGM shares declined 24 percent to $7.27 after dropping 1.04 percent on Monday.
- Versar Inc. VSR shares dropped 20.6 percent to $1.50. Versar posted FY16 operating loss (before taxes) of $36.6 million and gross revenue of $167.9 million.
- Cellect Biotechnology Ltd. APOP shares fell 20.5 percent to $8.67.
- Cancer Genetics Inc CGIX shares slipped 19.8 percent to $4.05. Cancer Genetics shares have jumped 81.65 percent over the past 52 weeks, while the S&P 500 index has gained 14.95 percent in the same period.
- Pareteum Corp TEUM shares declined 13.8 percent to $1.00. Pareteum is scheduled to report annual 2016 results on March 28.
- Aurinia Pharmaceuticals Inc AUPH shares dropped 10.9 percent to $6.90 after declining 3.49 percent on Monday.
- Regulus Therapeutics Inc RGLS fell 10.3 percent to $1.52. Regulus Therapeutics will present at the 16th Annual Needham Healthcare Conference on Tuesday, April 4, 2017.
- Digital Ally, Inc. DGLY dropped 8.7 percent to $4.20 after reporting downbeat quarterly results.
- New Concept Energy, Inc. GBR shares declined 7.8 percent to $2.49 after surging 53.41 percent on Monday.
- Snap Inc SNAP dropped 4.8 percent to $22.68. Analysts at Loop Capital initiated coverage on Snap with a Hold rating.
- Cempra Inc CEMP fell 4 percent to $4.18 after the company disclosed that it has withdrawn its solithromycin marketing authorization application in Europe.
- FactSet Research Systems Inc. FDS dropped 3.9 percent to $167.34. FactSet Research reported better-than-expected earnings for its fourth quarter, but sales missed estimates.
- Superconductor Technologies, Inc. SCON shares fell 3.1 percent to $1.49. Superconductors Technologies posted a Q4 loss of $0.61 per share.
- KVH Industries, Inc. KVHI declined 3.1 percent to $7.85. Raymond James downgraded KVH Industries from Strong Buy to Outperform.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in